Seres Therapeutics Announces Closing Of Initial Public Offering

Published: Jul 02, 2015

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the closing of its initial public offering of 8,545,138 shares of its common stock at an initial public offering price of $18.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,114,583 additional shares of common stock. The shares began trading on the NASDAQ Global Select Market under the ticker symbol "MCRB" on June 26, 2015. All of the shares of common stock in the offering were offered by the company. The net proceeds to Seres Therapeutics from the sale of shares in the offering are estimated to be approximately $139.8 million, after deducting the underwriting discounts and estimated offering expenses.

Help employers find you! Check out all the jobs and post your resume.

Back to news